Cargando…
Suppression of bone morphogenetic protein inhibitors promotes osteogenic differentiation: therapeutic implications
Bone morphogenetic proteins (BMPs) are expressed during osteogenesis and their action is regulated by corresponding BMP inhibitors. Chordin (a well recognized BMP inhibitor) and BMP-2 are expressed during osteogenic differentiation of human mesenchymal stem cells. Chordin inhibition induces human me...
Autores principales: | Heliotis, Manolis, Tsiridis, Eleftherios |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575635/ https://www.ncbi.nlm.nih.gov/pubmed/18710600 http://dx.doi.org/10.1186/ar2467 |
Ejemplares similares
-
Metabolomics Analysis of the Osteogenic Differentiation of Umbilical Cord Blood Mesenchymal Stem Cells Reveals Differential Sensitivity to Osteogenic Agents
por: Klontzas, Michail E., et al.
Publicado: (2017) -
Bone Morphogenetic Protein Receptor in the Osteogenic Differentiation of Rat Bone Marrow Stromal Cells
por: Wang, Anxun, et al.
Publicado: (2010) -
Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells
por: SUN, JIAN, et al.
Publicado: (2015) -
Bone Morphogenetic Protein-9 Promotes Osteogenic Differentiation and Mineralization in Human Stem-Cell-Derived Spheroids
por: Lee, Sung-Bin, et al.
Publicado: (2023) -
Bone morphogenetic proteins 2, 6, and 9 differentially regulate the osteogenic differentiation of immortalized preodontoblasts
por: Cao, Yuying, et al.
Publicado: (2020)